tradingkey.logo

Oncology Institute Inc

TOI
2.610USD
+0.160+6.53%
종가 02/06, 16:00ET시세는 15분 지연됩니다
254.66M시가총액
손실P/E TTM

Oncology Institute Inc

2.610
+0.160+6.53%

자세한 내용은 Oncology Institute Inc 회사

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.

Oncology Institute Inc 정보

종목 코드 TOI
회사 이름Oncology Institute Inc
상장일Mar 13, 2020
CEOVirnich (Daniel)
직원 수825
유형Ordinary Share
회계 연도 종료Mar 13
주소18000 Studebaker Rd
도시CERRITOS
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호90703
전화15627353226
웹사이트https://theoncologyinstitute.com/
종목 코드 TOI
상장일Mar 13, 2020
CEOVirnich (Daniel)

Oncology Institute Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.20M
+12675.00%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
289.09K
+91049.00%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
235.13K
-244.00%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
196.63K
+3594.00%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
98.04K
+98037.00%
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--
Mr. Brad Hively
Mr. Brad Hively
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
Ms. Karen M. Johnson
Ms. Karen M. Johnson
Independent Director
Independent Director
--
--
Ms. Anne Mcgeorge
Ms. Anne Mcgeorge
Independent Chairman of the Board
Independent Chairman of the Board
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Daniel Virnich, M.D.
Dr. Daniel Virnich, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.20M
+12675.00%
Dr. Mohit Kaushal
Dr. Mohit Kaushal
Independent Director
Independent Director
289.09K
+91049.00%
Mr. Robert Ross Carter
Mr. Robert Ross Carter
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
235.13K
-244.00%
Dr. Yale Podnos
Dr. Yale Podnos
Chief Medical Officer
Chief Medical Officer
196.63K
+3594.00%
Ms. Kristin England
Ms. Kristin England
Chief Administrative Officer
Chief Administrative Officer
98.04K
+98037.00%
Mr. Mark L. Pacala
Mr. Mark L. Pacala
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
사업별USD
이름
수익
비율
Dispensary revenue
75.89M
55.57%
FFS revenue
39.62M
29.01%
Capitated revenue
20.57M
15.07%
Clinical research trials and other revenue
474.00K
0.35%
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
사업별USD
이름
수익
비율
Dispensary revenue
75.89M
55.57%
FFS revenue
39.62M
29.01%
Capitated revenue
20.57M
15.07%
Clinical research trials and other revenue
474.00K
0.35%

주식 보유 통계

마지막 업데이트: Wed, Feb 4
마지막 업데이트: Wed, Feb 4
주주
주주 유형
주주
주주
비율
M33 Growth LLC
5.53%
Chernett (Jorey)
5.20%
The Vanguard Group, Inc.
4.83%
OncologyCare Partners LLC
4.18%
Deerfield Management Company, L.P.
3.42%
기타
76.85%
주주
주주
비율
M33 Growth LLC
5.53%
Chernett (Jorey)
5.20%
The Vanguard Group, Inc.
4.83%
OncologyCare Partners LLC
4.18%
Deerfield Management Company, L.P.
3.42%
기타
76.85%
주주 유형
주주
비율
Investment Advisor
12.45%
Hedge Fund
11.07%
Investment Advisor/Hedge Fund
10.11%
Individual Investor
10.09%
Venture Capital
5.53%
Corporation
4.18%
Research Firm
0.92%
Private Equity
0.26%
Bank and Trust
0.17%
기타
45.22%

기관 주식 보유

마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
172
39.71M
40.37%
-15.56M
2025Q3
145
39.72M
42.48%
-7.79M
2025Q2
119
39.72M
44.51%
-19.63M
2025Q1
137
46.36M
52.04%
-13.47M
2024Q4
138
45.05M
59.62%
-19.81M
2024Q3
139
50.89M
67.39%
-11.59M
2024Q2
143
57.80M
76.77%
-3.05M
2024Q1
146
56.10M
75.87%
-3.90M
2023Q4
143
57.48M
77.79%
-4.30M
2023Q3
176
58.70M
79.97%
-14.73M
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
M33 Growth LLC
5.44M
5.53%
-3.08M
-36.13%
Nov 18, 2025
The Vanguard Group, Inc.
4.55M
4.62%
+264.36K
+6.18%
Sep 30, 2025
OncologyCare Partners LLC
4.11M
4.18%
--
--
Mar 26, 2025
Deerfield Management Company, L.P.
3.36M
3.42%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.12M
3.17%
+119.92K
+4.00%
Sep 30, 2025
CenterBook Partners LP
2.70M
2.75%
+1.99M
+277.80%
Sep 30, 2025
Balyasny Asset Management LP
2.52M
2.56%
--
--
Sep 30, 2025
Kanen Wealth Management, LLC
1.84M
1.87%
+1.84M
--
Sep 30, 2025
Wexford Capital LP
1.57M
1.6%
+452.39K
+40.44%
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Vanguard US Momentum Factor ETF
0.11%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Vanguard US Momentum Factor ETF
비율0.11%
iShares Micro-Cap ETF
비율0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
비율0.03%
Global X Russell 2000 ETF
비율0.01%
ProShares Hedge Replication ETF
비율0.01%
iShares Russell 2000 ETF
비율0.01%
Proshares Ultra Russell 2000
비율0.01%
ProShares UltraPro Russell2000
비율0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
비율0.01%
iShares Russell 2000 Growth ETF
비율0.01%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI